🚨 Buffett würde diese 3 Aktien kaufen!
2 extracted signals · 2 resolved · 0 still active
DER-RENTNER | BÖRSE & KRYPTOIndependent analyst profile- Source published
- 13 Jun 2026, 07:00 UTC
- Recorded by Tahlil Plus
- 30 Jul 2026, 04:05 UTC
AI-generated source summary
The analysis covers three stocks: UnitedHealth (UNH), Novo Nordisk (NOVO_B), and Illumina (ILMN). For UNH, the current price is $405.55, with a bullish outlook targeting $450.0, and a fail bound at $390.0. Novo Nordisk is trading at 37.68 EUR, with a bullish bias towards 45.0 EUR and a stop loss at 35.0 EUR. Illumina (ILMN) is analyzed with a current price of $166.21, showing a bearish trend with a target of $200.0 and a failure point at $150.0. The video also touches on the technical indicators and growth charts for Novo Nordisk and UnitedHealth, highlighting positive growth rates for Novo Nordisk and a mixed but generally upward trend for UnitedHealth, despite a recent dip. Illumina's chart shows a significant downtrend from its peak, with technical indicators suggesting further downside potential. The analysis concludes that while Novo Nordisk and UnitedHealth show strong fundamentals and growth prospects, Illumina faces headwinds due to increasing competition and potentially overvalued growth expectations.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
DER-RENTNER | BÖRSE & KRYPTO
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.